These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1255285)

  • 1. The beta-phenacyl ester as a temporary protecting group to minimize cyclic imide formation during subsequent treatment of aspartyl peptides with HF.
    Yang CC; Merrifield RB
    J Org Chem; 1976 Mar; 41(6):1032-41. PubMed ID: 1255285
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of a cyclic imide in aspartyl or asparaginyl glycyl peptides induced by heating in the dry state.
    Luo SQ; Liao CX; McClelland JF; Graves DJ
    Int J Pept Protein Res; 1987 Jun; 29(6):728-33. PubMed ID: 3623803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of aminosuccinyl derivative from beta-phenacyl aspartyl peptides catalyzed by sodium thiophenoxide.
    Gaudreau P; Morell JL; Gross E
    Int J Pept Protein Res; 1982 Mar; 19(3):280-3. PubMed ID: 7118398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aspartimide formation: the effects of protecting groups, acid, base, temperature and time.
    Tam JP; Riemen MW; Merrifield RB
    Pept Res; 1988; 1(1):6-18. PubMed ID: 2980781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-acids and peptides. Part XVII. Synthesis of cyclo-[(O-t-butyl)-L-seryl-beta-alanyl-glycyl-(O-methyl)-L-beta-aspartyl], and observations on the rearrangement of beta-aspartyl peptides esters.
    Handa BK; Hassall CH
    J Chem Soc Perkin 1; 1976; (19):2014-9. PubMed ID: 1033193
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of an aspartic acid-containing protected peptide. Alternatives for overcoming a side reaction during HF treatment.
    Robles J; Pedroso E; Grandas A
    Int J Pept Protein Res; 1994 Apr; 43(4):359-62. PubMed ID: 8045681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of cyclic imide-like structures upon the treatment of calmodulin and a calmodulin peptide with heat.
    Martin BL; Wu D; Tabatabai L; Graves DJ
    Arch Biochem Biophys; 1990 Jan; 276(1):94-101. PubMed ID: 2105083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha- and beta- aspartyl peptide ester formation via aspartimide ring opening.
    Stathopoulos P; Papas S; Kostidis S; Tsikaris V
    J Pept Sci; 2005 Oct; 11(10):658-64. PubMed ID: 15884102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of aspartyl beta-phenacyl esters by selenophenol under neutral conditions.
    Morell JL; Gaudreau P; Gross E
    Int J Pept Protein Res; 1982 May; 19(5):487-9. PubMed ID: 7118418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SN 1 and SN 2 mechanisms for the deprotection of synthetic peptides by hydrogen fluoride. Studies to minimize the tyrosine alkylation side reaction.
    Tam JP; Heath WF; Merrifield RB
    Int J Pept Protein Res; 1983 Jan; 21(1):57-65. PubMed ID: 6826283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of protecting groups for the beta-carboxylic group of aspartic acid that minimize base-catalyzed aspartimide formation.
    Karlström A; Undén A
    Int J Pept Protein Res; 1996 Oct; 48(4):305-11. PubMed ID: 8919050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and control of aspartimide formation in the synthesis of cyclic peptides.
    Flora D; Mo H; Mayer JP; Khan MA; Yan LZ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1065-8. PubMed ID: 15686913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on cyclic RGD analogues.
    Davies JS; Enjalbal C; Wise C; Jones G; Handa BK
    Biochem Soc Trans; 1994 Nov; 22(4):1049-52. PubMed ID: 7698405
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-turns in bridged proline-containing cyclic peptide models.
    Hollósi M; Kövér KE; Holly S; Radics L; Fasman GD
    Biopolymers; 1987 Sep; 26(9):1555-72. PubMed ID: 3663873
    [No Abstract]   [Full Text] [Related]  

  • 15. Deamidation via cyclic imide in asparaginyl peptides.
    Capasso S; Mazzarella L; Sica F; Zagari A
    Pept Res; 1989; 2(2):195-200. PubMed ID: 2520758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on cyclic peptides. 5. Conformation and interaction with small molecules of cyclic hexapeptides containing glutamic acid or aspartic acid residue.
    Sugihara T; Imanishi Y; Higashimura T; Shimonishi Y
    J Org Chem; 1976 Jul; 41(15):2584-90. PubMed ID: 940011
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-turns in serine-containing linear and cyclic models.
    Hollósi M; Kövér KE; Holly S; Fasman GD
    Biopolymers; 1987 Sep; 26(9):1527-53. PubMed ID: 3117129
    [No Abstract]   [Full Text] [Related]  

  • 18. Automated ion-exchange chromatography of alpha- and beta-aspartyl oligopeptides.
    Dorer FE; Haley EE; Buchanan DL
    Anal Biochem; 1967 May; 19(2):366-73. PubMed ID: 6048705
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic peptide synthesis with thioacids.
    Sasaki K; Crich D
    Org Lett; 2010 Jul; 12(14):3254-7. PubMed ID: 20568826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic protein carboxyl methylation at physiological pH: cyclic imide formation explains rapid methyl turnover.
    Johnson BA; Aswad DW
    Biochemistry; 1985 May; 24(10):2581-6. PubMed ID: 4016073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.